Menu
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Buy Currently
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Sample Portfolio
Sample Portfolio Analysis
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Account Requirements
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
Municipal Bond Presentation
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
home
about us
Investment Approach
Client Service Approach
Market Analysis Summary
Mission Statement
Value Proposition
Team Biographies
Firm ADV PDFs
Form CRS
Firm Brochure-Part 2A of Form ADV
Brochure Supplement Amit Stavinsky
Brochure Supplement Frank Parks
Brochure Supplement Dominick Savo
Brochure Supplement Richard Mason
Brochure Supplement Joe Estes
Brochure Supplement Jonathan Ezra
Statement Of Financial Strength
Job Opportunities
Tamar Advisors
Own Your Practice
Letter to Clients
member log-in
contact us
PRODUCTS
Fixed Income Portfolio (FIP)
FIP Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Market (TAM)
TAM sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Fund (TAF)
TAF sm Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Market Value Securities (MVS)
MVS Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Total Asset Value (TAV)
TAV Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
Municipal Bonds
Taxable Bonds
Par, Premium, and Discount Bonds
Rating and Analyzing Bonds
Refunding & Pre-refunding
Bond Yields
Yield Curve
Secured Bonds
Mortgage Bonds
Unsecured Bonds
Debentures
Subordinated Debentures
Zero-Coupon Bonds
Convertible Bonds
High Yield Dividend Stocks
Independent Money Managers
Fees & Compensation
Corporate Cash Management
Fees & Compensation
Estate Planning
Financial Planning
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
Professional Alliance Network
Client Service Approach
Client's Responsibilities
Fees
Implementation
Legal Services
Termination
MUNICIPAL BONDS
Municipal Bond Presentation
About Us
The Management
Global Asset Allocation Products
FIP Program
Classifying Municipal Bonds
Revenue Bonds
Credit Factors Affecting General Obligation Bonds
Credit Factors Affecting the Quality of Local Municipal Bonds
Analyzing the Credit Quality of General Obligation Bonds
Analyzing the Credit Quality of Revenue Municipal Bonds
What We Normally Buy
What We Normally Don’t Buy
Municipal Bonds – Unique Asset Class
Default Rates
Yield Difference
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same-Day Allocation
TSL’s Turnkey Operation Platform
Classifying Municipal Bonds
Revenue Municipal Bonds
Types of Revenue Municipal Bonds
Industrial Development Revenue Bonds
Lease-back Bonds
Special Tax Bonds
NHA/PHA Bonds
Moral Obligation Bonds
Municipal Notes
TANs/RANs
BANs
CLNs/GANs
Variable Rate Bonds/Notes
Build America Bonds
Double-Barreled Bonds
Bond Index Components
Open-end-Closed-end-Indenture
Sinking Fund
Bond Contracts
Bond Indenture
Official Statement
Bond Issuance Process
Analyzing GO Bonds
Analyzing Revenue Bonds
Debt Ratios
General Price Analysis of Municipal Bonds
Liquidity
Interest Rate Risk
Credit Risk
Coupon Risk
Maturity Risk
Municipal Bond Insurance
Municipal Bonds Unique Asset Class
Default Rates
What We Buy Currently
What We Normally Don’t Buy
Turnkey Operation Platform
Advantages of Our Bid Wanted System
Advantages of Our Clearing System
Preferred Custodian Settlement
Advantages of Same Day Allocation
Traditional Broker/Dealer Execution Flow
TSL's Turnkey Operation Platform
INDEX FUNDS
Total Asset Fund (TAF)
TAF® Program
Services, Fees and Compensation
Client Information
Client Contact with Portfolio Manager(s)
Additional Information
Sample Portfolio
Back Dated Performance Reports
Quarterly Performance Reports
EVENTS
FIP
Event Schedule
TAM
Event Schedule
Total Asset Market (TAM sm) Presentation
TAF
Event Schedule
Total Asset Fund (TAF sm) Presentation
MVS
Event Schedule
Market Value Securities (MVS sm) Presentation
Featured Event
Calendar of Events
Events History
Investing During Uncertain Times
Read FULL Seminar Here
Tax-Free Income Seminar
Bond Fund Seminar
RSVP-Signup Form
MARKET RESEARCH
Featured Quarterly Newsletter
Featured Articles
Contrarian Notes Blog
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Pharma/Biotech
Recent news which mentions Pharma/Biotech
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Capricor Therapeutics’ CAP-1002: Regulatory Progress, Clinical Outcomes & Investment Outlook
April 06, 2025
Tickers
CAPR
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
When Penny Stocks Can Become Compelling: A Long-Term Buy With CYDY
April 03, 2025
Tickers
CYDY
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
The Canadian Cannabis Report - Monday, March 31
April 01, 2025
Tickers
CGC
CNBS
CRON
MJ
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
SenesTech: A Little-Known Biotech Company Worthy Of Attention
April 01, 2025
Tickers
AMZN
SNES
TSCO
WMT
Tags
Market News
Consumer Goods
Stocks / Equities
From
TalkMarkets
FDA Advisory Committee Shakeup and Implications for Capricor Therapeutics
April 01, 2025
Tickers
CAPR
CYDY
MESO
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Competitive Analysis In The ATTR-CM Field
March 30, 2025
Tickers
ALNY
AZN
BBIO
IONS
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Gilead Sciences - Leader In HIV Medicines
March 14, 2025
Tickers
GILD
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
SenesTech CEO Interview: Breaking Down Record Earnings & The Road To Profitability
March 13, 2025
Tickers
AMZN
SNES
TSCO
WMT
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Benitec - Another Biopharma Rocket
March 13, 2025
Tickers
BNTC
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Pavella - Undiscovered Biotechnology Stock
March 12, 2025
Tickers
PVLA
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
Xeris Biopharma - Possibly The Best Pharma Stock
March 11, 2025
Tickers
XERS
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Healthcare Stocks Doing Well But SMID Biotech Looking A Little Frazzled
March 10, 2025
Tickers
ADPT
ARKG
CRMD
GH
Tags
Market News
Healthcare
ETFs
From
TalkMarkets
Healthcare Sector Trying To Bounce Back
March 09, 2025
Tickers
BMY
FBT
IBB
ISRG
Tags
Market News
Healthcare
ETFs
From
TalkMarkets
BASF SE: Can Cost-Cutting And Strategic Restructuring Fuel Seasonal Upside?
March 06, 2025
Tickers
BASFY
BFFAF
Tags
Market News
Stocks / Equities
Pharma/Biotech
From
TalkMarkets
SenesTech: The Smart Money’s Bet On Rodent Population Control
March 05, 2025
Tickers
AMZN
SNES
TSCO
WMT
Tags
Market News
Consumer Goods
Stocks / Equities
From
TalkMarkets
Biotech Rally Coming In Weeks Ahead?
March 04, 2025
Tickers
ARKG
IBB
IHF
IHI
Tags
Pharma/Biotech
Stocks / Equities
Healthcare
From
TalkMarkets
Biotech Stocks Stay Strong Through A Period Of Uncertainty In The Market
February 24, 2025
Tickers
ABT
IHI
ISRG
JNJ
Tags
Stocks / Equities
Pharma/Biotech
ETFs
From
TalkMarkets
Synchronicity: Denying The Unexplainable
February 24, 2025
Tickers
AMGN
ARKG
AZN
BIIB
Tags
Market News
Pharma/Biotech
Stocks / Equities
From
TalkMarkets
Large Cap Biopharmaceutical Metrics And Performance Q1 2025
February 20, 2025
Tickers
ABBV
AMGN
BMY
GILD
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
SenesTech Has Built A Better Mouse Trap
February 19, 2025
Tickers
AMZN
SNES
TSCO
WMT
Tags
Stocks / Equities
Pharma/Biotech
Capital & Industrial Goods
From
TalkMarkets
Biotech Stocks Had A Good Week Despite Crosscurrents
February 18, 2025
Tickers
ARKG
IBB
ILMN
UNH
Tags
ETFs
Healthcare
Market News
From
TalkMarkets
Healthcare And Biotech Playbook As Disruption Gathers Force
February 10, 2025
Tickers
ABBV
BDX
GILD
LLY
Tags
Healthcare
ETFs
Market News
From
TalkMarkets
Can Biotech Stocks Survive The Precarious Macro?
February 03, 2025
Tickers
ABBV
BMY
GILD
IBB
Tags
Healthcare
Market News
Pharma/Biotech
From
TalkMarkets
Top Picks For 2025: Skye Bioscience
February 02, 2025
Tickers
NVO
SKYE
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
Small- To Mid-Cap Biotech Trades Poised For Gains
February 01, 2025
Tickers
ABBV
ARKG
IBB
NTRA
Tags
Market News
Healthcare
ETFs
From
TalkMarkets
Biotech And Healthcare Stocks Poised For Gains Ahead
January 27, 2025
Tickers
ABBV
BDX
BMY
IHI
Tags
Pharma/Biotech
Stocks / Equities
Market News
From
TalkMarkets
Healthcare And Biotech Stocks Lag The Market Again
January 20, 2025
Tickers
ABBV
IBB
IHI
ISRG
Tags
Healthcare
Market News
Stocks / Equities
From
TalkMarkets
AI Drug Discovery Startups: Analysis Of Exscientia’s Acquisition By Recursion
January 18, 2025
Tickers
MRK
RXRX
SNY
Tags
Stocks / Equities
Pharma/Biotech
Market News
From
TalkMarkets
ETFs In Focus Post UnitedHealth's Mixed Q4 Results
January 18, 2025
Tickers
FHLC
IHF
IYH
UNH
Tags
ETFs
Healthcare
Market News
From
TalkMarkets
Two Big Weeks To Play A Rally In Biotech And Healthcare Stocks
January 06, 2025
Tickers
ADPT
ARKG
BDX
CRMD
Tags
Pharma/Biotech
Stocks / Equities
ETFs
From
TalkMarkets
< Previous
1
2
3
4
5
6
7
8
9
...
32
33
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.